HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim Van den Noortgate Selected Research

Wim Van den Noortgate Research Topics

Disease

1Genetic Risk Score
01/2020
1Moyamoya Disease (Moya-Moya Disease)
09/2019
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2017

Drug/Important Bio-Agent (IBA)

1Oxytocin (Pitocin)FDA LinkGeneric
01/2020
1Vasopressins (Vasopressin)IBA
01/2020
1Bupropion (Wellbutrin)FDA LinkGeneric
10/2017

Therapy/Procedure

1Conservative Treatment
09/2019